Scott Kellen
2019
In 2019, Scott Kellen earned a total compensation of $677.8K as Chief Financial Officer and Secretary at DiaMedica Therapeutics, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $64,800 |
|---|---|
| Option Awards | $336,557 |
| Salary | $262,500 |
| Other | $13,950 |
| Total | $677,807 |
Kellen received $336.6K in option awards, accounting for 50% of the total pay in 2019.
Kellen also received $64.8K in non-equity incentive plan, $262.5K in salary and $14K in other compensation.
Rankings
In 2019, Scott Kellen's compensation ranked 10,808th out of 13,971 executives tracked by ExecPay. In other words, Kellen earned more than 22.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,808 out of 13,971 | 23rd |
Division Manufacturing | 4,373 out of 5,701 | 23rd |
Major group Chemicals And Allied Products | 1,704 out of 2,200 | 23rd |
Industry group Drugs | 1,459 out of 1,886 | 23rd |
Industry Pharmaceutical Preparations | 1,078 out of 1,398 | 23rd |
Source: SEC filing on April 20, 2020.
Kellen's colleagues
We found two more compensation records of executives who worked with Scott Kellen at DiaMedica Therapeutics in 2019.
News
DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
April 4, 2024
DiaMedica Therapeutics CEO Rick Pauls' 2022 pay slips 5% to $1.1M
April 4, 2023
DiaMedica Therapeutics CEO Rick Pauls' 2021 pay jumps 29% to $1.1M
April 5, 2022
DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
April 20, 2020
DiaMedica Therapeutics CEO Rick Pauls' 2018 pay jumps 46% to $734K
April 8, 2019